BioSpecifics Technologies (BSTC) Short Interest Ratio & Short Volume

Short interest is the volume of BioSpecifics Technologies shares that have been sold short but have not yet been covered or closed out. As of November 15th, traders have sold 74,100 shares of BSTC short. 1.28% of BioSpecifics Technologies' shares are currently sold short. Learn More on BioSpecifics Technologies' current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. BSTC shares currently have a short interest ratio of 1.0. Learn More on BioSpecifics Technologies's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.28% of BioSpecifics Technologies' floating shares are currently sold short.

BioSpecifics Technologies saw a increase in short interest during the month of November. As of November 15th, there was short interest totaling 74,100 shares, an increase of 22.5% from the previous total of 60,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

BioSpecifics Technologies currently has issued a total of 7,345,000 shares. Some of BioSpecifics Technologies' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. BioSpecifics Technologies currently has a public float of 5,780,000 shares.

1.28% of BioSpecifics Technologies' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to BioSpecifics Technologies: OPKO Health, Inc. (28.56%), Lexicon Pharmaceuticals, Inc. (8.90%), Innoviva, Inc. (18.15%), XOMA Co. (2.36%), Verastem, Inc. (3.10%), Vanda Pharmaceuticals Inc. (4.57%), MannKind Co. (13.21%), Rigel Pharmaceuticals, Inc. (2.86%), Gossamer Bio, Inc. (4.77%), Regulus Therapeutics Inc. (9.44%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.92 billion), Aon plc ($3.86 billion), Analog Devices, Inc. ($3.55 billion), The Clorox Company ($2.87 billion), Snap Inc. ($2.78 billion), Moderna, Inc. ($2.21 billion), The Kroger Co. ($2.05 billion), International Flavors & Fragrances Inc. ($1.98 billion), Expedia Group, Inc. ($1.93 billion), and Match Group, Inc. ($1.59 billion). View all of the most shorted stocks.

Short selling BSTC is an investing strategy that aims to generate trading profit from BioSpecifics Technologies as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for BioSpecifics Technologies occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of BSTC, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BSTC, twice per month. The most recent reporting period available is November, 15 2020.